Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kimberly Manhard Insider Profile
11 Followers
Kimberly Manhard, EVP, Drug Development at Heron Therapeutics, holds 28.33K shares in Heron Therapeutics (Ticker: HRTX), holds ― shares in Inhibrx (Ticker: ~INBX), holds 10.00K shares in Inhibrx Biosciences Inc (Ticker: INBX).
Kimberly Manhard Heron Therapeutics (HRTX)EVP, Drug Development
Heron Therapeutics (HRTX)
EVP, Drug Development
Ranked #39,556 out of 99,335 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+18.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kimberly Manhard holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 03, 2015 - Jun 03, 2016
Return:+24.90%
The most profitable trade made by Kimberly Manhard
Kimberly Manhard's Trading History
Heron Therapeutics
Apr 17, 2023
EVP, Drug Development
Uninformative Buy
12.66K
$52.13K
Inhibrx
―
―
―
―
Inhibrx Biosciences Inc
Aug 30, 2024
Director
Informative Buy
139.80K
$160.00K
List of latest transactions for each holding click on a transaction to see Kimberly Manhard's performance on stock
You May Also Like
Kimberly Manhard insider profile FAQ
What is the percentage of profitable transactions made by Kimberly Manhard?
The percentage of profitable transactions made by Kimberly Manhard is 100%.
What is the average return per transaction made by Kimberly Manhard?
The average return per transaction made by Kimberly Manhard is 18.10%.
What stocks does Kimberly Manhard hold?
Kimberly Manhard holds: HRTX, ~INBX, INBX stocks.
What was Kimberly Manhard’s latest transaction?
Kimberly Manhard latest transaction was an Uninformative Buy of $12.66K.
What was Kimberly Manhard's most profitable transaction?
Kimberly Manhard’s most profitable transaction was an Informative Sell of HRTX stock on June 3, 2015. The return on the trade was 24.90%.
What is Kimberly Manhard's role in Heron Therapeutics?
Kimberly Manhard's role in Heron Therapeutics is EVP, Drug Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.